About Aprea Therapeutics
Aprea Therapeutics develops novel cancer therapeutics that restore the tumor suppressor function of p53, targeting hematological malignancies and solid tumors.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to Aprea Therapeutics. Response typically within 48 hours.
Company Info
TypePublic
StockAPRE (NASDAQ)
Founded2015
Employees60
Revenue$8M
HQBoston, USA